Clinical update
COVID-19 and Peripheral Neuropathy
At present, there is no reason to believe that COVID-19 is responsible for any sensory defects of the lower extremity. In fact, The Foundation for Peripheral Neuropathy, a reputable patient advocacy group with a highly qualified scientific advisory board, recently sent an email to their members stating that it:
On a personal note, I would like to take this opportunity to wish all of you the best of luck during these trying times. These are truly dark days, but they will pass.
Related clinical updates
Clinical update
A Common-Sense Approach for the Nutritional Treatment of Peripheral Neuropathy (Chiropractic Edition)
December 18, 2022Dr. Howard Benedikt & Dr. Richard H. Mann
Clinical update
Improving Outcomes in the Treatment of Peripheral Neuropathy with Low-Level Laser Therapy: Photobiomodulation, Neuropathy, and Benfotiamine
December 12, 2022Dr. Howard Benedikt & Dr. Richard H. Mann
Clinical update
How Many People in the U.S. Have Peripheral Neuropathy?
July 8, 2022Dr. Richard H. Mann
Stay in the loop
New research, plainly explained.
One short email when a study lands that meaningfully changes the picture. No spam, no products.
You can unsubscribe at any time.